Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Zdravko Mitrović"'
Autor:
Igor Aurer, Ozren Jakšić, Sandra Bašić-Kinda, Stefan Mrđenović, Slobodanka Ostojić-Kolonić, Dominik Lozić, Hrvoje Holik, Sabina Novaković-Coha, Petra Berneš, Ivan Krečak, Martina Morić-Perić, Marino Narančić, Zdravko Mitrović, Toni Valković
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 331 (2024)
Patients with lymphoid malignancies are at increased risk of death or prolonged infection due to COVID-19. Data on the influence of different antineoplastic treatment modalities on outcomes are conflicting. Anti-CD20 monoclonal antibodies increase th
Externí odkaz:
https://doaj.org/article/4511e1e613e74b6983e3aef21eb96186
Publikováno v:
Southeastern European Medical Journal, Vol 5, Iss 2, Pp 18-26 (2021)
Aim: Deep vein thrombosis (DVT) is a common clinical condition encountered in the emergency department (ED). The aim of this study was to compare the characteristics and outcomes of patients with respect to treatment using novel oral anticoagulants (
Externí odkaz:
https://doaj.org/article/11f245a7b55e41e0be9eb94ea764083a
Autor:
Lucija Galiot, Zdravko Mitrović
Publikováno v:
Liječnički vjesnik, Vol 145, Iss Supp 2, Pp 68-68 (2023)
Multiple myeloma is a proliferation of neoplastic plasma cells producing a monoclonal protein (M-protein). Multiple myeloma can present in various ways with anemia, renal failure, hypercalcemia, and bone fractures as the most common signs.
Externí odkaz:
https://doaj.org/article/ab9d2bd1603c448dae3dea78c2a30908
Autor:
Dora Bežovan, Zdravko Mitrović
Publikováno v:
Medicina Fluminensis. 58:238-248
Trombocitopenija je česta u virusnim infekcijama, prisutna je u prosječno 18 % oboljelih od bolesti COVID-19, a obično je blaga (u rasponu od 100 do 150 × 10^9/L). Zastupljenija je među teže oboljelima i predstavlja neovisan čimbenik rizika za
Autor:
Renata Huzjan Korunic, Petar Gaćina, Vlatko Pejša, Željko Prka, Zdravko Mitrović, Željko Jonjić, Marija Ivic, Ozren Jakšić, Josipa Vlasac Glasnovic, Amina Fazlić Džankić, Marko Lucijanic, Mario Piršić
Publikováno v:
Wiener klinische Wochenschrift. 134(1-2)
We retrospectively investigated clinical and prognostic significance of psoas muscle index (PMI) calculated as total psoas muscle area at L3 vertebra level obtained from baseline computed tomography (CT) scans in 49 newly diagnosed classical Hodgkin'
Autor:
Sandra Bašić-Kinda, Karla Mišura Jakobac, Marinka Jakić-Bubalo, Igor Aurer, Dubravka Županić Krmek, Jasminka Sinčić-Petričević, Delfa Radić-Krišto, Božena Coha, Zdravko Mitrović, Marijo Vodanović, Aron Grubešić, Dajana Deak, Barbara Dreta
Publikováno v:
Croatian medical journal
Volume 62
Issue 5
Croatian Medical Journal
Volume 62
Issue 5
Croatian Medical Journal
Aim: To compare the outcomes of Croatian patients with mantle cell lymphoma (MCL) who started treatment in 2007 and 2008 (historical cohort) and of those who started treatment between 2015 and 2017 (recent cohort). ----- Methods: The historical cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82695343858e924185e661f5408b08ef
https://repository.medri.uniri.hr/islandora/object/medri:7336/datastream/FILE0
https://repository.medri.uniri.hr/islandora/object/medri:7336/datastream/FILE0
Autor:
Marko Lucijanic, Vlatko Pejša, Ozren Jakšić, Zeljko Prka, Marija Ivic, Zdravko Mitrović, Mario Piršić, Zeljko Jonjic, Anamarija Vrkljan Vuk, Tajana Štoos-Veić, Amina Fazlic Dzankic
First obinutuzumab application is associated with infusion related reactions (IRRs) that may discourage further continuation of the drug. During our clinical practice we have observed that chronic lymphocytic leukemia (CLL) patients with autoimmune h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::984d67b2e6cf2c1ca499322a39f765b3
https://urn.nsk.hr/urn:nbn:hr:105:272145
https://urn.nsk.hr/urn:nbn:hr:105:272145
Autor:
Željko Prka, Mario Knežević, Zdravko Mitrović, Radmila Ajduković, Josip Baković, Ozren Jakšić, Višnja Hariš, Vlatko Pejša, Mario Piršić, Igor Stipančić
Publikováno v:
Liječnički vjesnik. 140:248-253
Autor:
Hrvoje Holik, Petra Bernes, Slobodanka Ostojić Kolonić, Toni Valković, Zdravko Mitrović, Ivan Krečak, Marino Narancic, Sabina Novakovic Coha, Sandra Bašić-Kinda, Dominik Lozić, Stefan Mrdenovic, Ozren Jakšić, Martina Moric Peric, Igor Aurer
Publikováno v:
Blood
Patients with lymphoid malignancies are at increased risk of death due to COVID19. Currently, it is not completely clear whether this is mainly due to disease biology or to anti-lymphoma treatment and whether the prognosis of infection differs in pat
Autor:
Marija Ivic, Branimir Jakšić, Mario Piršić, David Cicic, Ozren Jakšić, Vlatko Pejša, Rajko Kusec, Zdravko Mitrović
Publikováno v:
Blood. 136:14-15
There is a high number of clinical and biological parameters with impact on prognosis in B-CLL and number of successful prognostic models were developed (clinical stages, CLL IPI, MDACC score, etc.). However, rapidly changing therapeutic landscape wi